Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity

被引：0
|
作者：
Gruber, M. L. [1 ,2 ,3 ]
Raza, S. [1 ,2 ,3 ]
Gruber, D. [1 ,2 ,3 ]
Narayana, A. [1 ,2 ,3 ]
机构：
[1] NYU, Ctr Clin Canc, New York, NY USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2017
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma
    Wick, Wolfgang
    Chinot, Olivier L.
    Bendszus, Martin
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Revil, Cedric
    Kerloeguen, Yannick
    Cloughesy, Timothy
    [J]. NEURO-ONCOLOGY, 2016, 18 (10) : 1434 - 1441
  • [42] OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL WITH BEVACIZUMAB AND NON-BEVACIZUMAB-BASED REGIMENS IN PATIENTS WITH RECURRENT GLIOBLASTOMA FROM UNITED STATES COMMUNITY PRACTICES
    Chen, Clara
    Ravelo, Arliene
    Yu, Elaine
    Dhanda, Rahul
    Schnadig, Ian D.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 44 - 44
  • [43] Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience
    Jalali, R.
    Basu, A.
    Gupta, T.
    Munshi, A.
    Menon, H.
    Sarin, R.
    Goel, A.
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 2007, 21 (06) : 583 - 587
  • [44] Impact of Etiological Cytogenetic Abnormalities on Immunoparesis and Progression-Free and Overall Survival in Newly Diagnosed Multiple Myeloma
    Caro, Jessica
    Cairns, David
    Menzies, Tom
    Pawlyn, Charlotte
    Boyle, Eileen M.
    Morgan, Gareth
    Cook, Gordon
    Kaiser, Martin F.
    Owen, Roger G.
    Gregory, Walter M.
    Jackson, Graham H.
    Walker, Brian
    Heaney, Jennifer Lj
    Drayson, Mark T.
    Davies, Faith E.
    [J]. BLOOD, 2020, 136
  • [45] CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Phillips, Heidi
    Sandmann, Thomas
    Li, Congfen
    Cloughesy, Timothy
    Chinot, Olivier L.
    Wick, Wolfgang
    Nishikawa, Ryo
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Lai, Albert
    Moore, Nicola
    Hegde, Priti
    Abrey, Lauren
    Bourgon, Richard
    Garcia, Josep
    Bais, Carlos
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [46] Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine
    D. H. Heiland
    W. Masalha
    P. Franco
    M. R. Machein
    A. Weyerbrock
    [J]. Journal of Neuro-Oncology, 2016, 126 : 567 - 575
  • [47] Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine
    Heiland, D. H.
    Masalha, W.
    Franco, P.
    Machein, M. R.
    Weyerbrock, A.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 126 (03) : 567 - 575
  • [48] Relationship between overall survival and progression-free survival for recent NCCTG glioblastoma multiforme trials
    Wu, Wenting
    Galanis, Evanthia
    Buckner, Jan C.
    Jaeckle, Kurt A.
    Sargent, Daniel J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
    Hemmati, Saman Moritz
    Ghadjar, Pirus
    Gruen, Arne
    Badakhshi, Harun
    Zschaeck, Sebastian
    Senger, Carolin
    Acker, Gueliz
    Misch, Martin
    Budach, Volker
    Kaul, David
    [J]. RADIATION ONCOLOGY, 2019, 14 (01)
  • [50] Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma
    Saman Moritz Hemmati
    Pirus Ghadjar
    Arne Grün
    Harun Badakhshi
    Sebastian Zschaeck
    Carolin Senger
    Güliz Acker
    Martin Misch
    Volker Budach
    David Kaul
    [J]. Radiation Oncology, 14
12345